GlaxoSmithKline Consumer Nigeria Plc released its unaudited results for the first quarter of the year (Q1, 2021).
- Revenue for the period was N3.5 billion. (-30.6% YoY)
- Cost of sales was N2.4 billion. (-30.6% YoY)
- Administrative expenses totalled N502.96 million. (+0.3% YoY)
- Loss for the period was N238.07 million
- Loss per share from continuing operations was 20 kobo.
See link to results.
